169 related articles for article (PubMed ID: 12650784)
21. [Effects of supplementation with the antioxidant flavonoid, silymarin, in chronic hepatitis C patients treated with peg-interferon + ribavirin. A placebo-controlled double blind study].
Pár A; Roth E; Miseta A; Hegedüs G; Pár G; Hunyady B; Vincze A
Orv Hetil; 2009 Jan; 150(2):73-9. PubMed ID: 19103558
[TBL] [Abstract][Full Text] [Related]
22. Meta-analysis: amantadine may lower the efficacy of pegylated interferon plus ribavirin in treatment-naive hepatitis C genotype 1 patients.
Chen J; Shi J; Xie WF; Zeng X; Lin Y
Int J Infect Dis; 2012 Oct; 16(10):e748-52. PubMed ID: 22836046
[TBL] [Abstract][Full Text] [Related]
23. Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms.
Gordon CE; Uhlig K; Lau J; Schmid CH; Levey AS; Wong JB
Am J Kidney Dis; 2008 Feb; 51(2):263-77. PubMed ID: 18215704
[TBL] [Abstract][Full Text] [Related]
24. Decrease in serum hepatitis C viral RNA during alpha-interferon therapy for chronic hepatitis C.
Shindo M; Di Bisceglie AM; Cheung L; Shih JW; Cristiano K; Feinstone SM; Hoofnagle JH
Ann Intern Med; 1991 Nov; 115(9):700-4. PubMed ID: 1656828
[TBL] [Abstract][Full Text] [Related]
25. [Xiaochaihu Tang for treatment of chronic hepatitis B: a systematic review of randomized trials].
Qin XK; Li P; Han M; Liu JP
Zhong Xi Yi Jie He Xue Bao; 2010 Apr; 8(4):312-20. PubMed ID: 20388470
[TBL] [Abstract][Full Text] [Related]
26. Antiviral therapy for recurrent liver graft infection with hepatitis C virus.
Gurusamy KS; Osmani B; Xirouchakis E; Burroughs AK; Davidson BR
Cochrane Database Syst Rev; 2009 Jan; (1):CD006803. PubMed ID: 19160303
[TBL] [Abstract][Full Text] [Related]
27. Antiviral prophylactic intervention for chronic hepatitis C virus in patients undergoing liver transplantation.
Gurusamy KS; Tsochatzis E; Davidson BR; Burroughs AK
Cochrane Database Syst Rev; 2010 Dec; (12):CD006573. PubMed ID: 21154370
[TBL] [Abstract][Full Text] [Related]
28. Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin.
Pivert A; Payan C; Morand P; Fafi-Kremer S; Deshayes J; Carrat F; Pol S; Cacoub P; Perronne C; Lunel F
J Clin Microbiol; 2006 Feb; 44(2):417-22. PubMed ID: 16455894
[TBL] [Abstract][Full Text] [Related]
29. Chinese medicinal herbs for influenza.
Chen XY; Wu TX; Liu GJ; Wang Q; Zheng J; Wei J; Ni J; Zhou LK; Duan X; Qiao JQ
Cochrane Database Syst Rev; 2005 Jan; (1):CD004559. PubMed ID: 15674953
[TBL] [Abstract][Full Text] [Related]
30. Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation.
De Vera ME; Smallwood GA; Rosado K; Davis L; Martinez E; Sharma S; Stieber AC; Heffron TG
Transplantation; 2001 Mar; 71(5):678-86. PubMed ID: 11292302
[TBL] [Abstract][Full Text] [Related]
31. Pegylated-interferon and ribavirin in liver transplant candidates and recipients with HCV cirrhosis: systematic review and meta-analysis of prospective controlled studies.
Xirouchakis E; Triantos C; Manousou P; Sigalas A; Calvaruso V; Corbani A; Leandro G; Patch D; Burroughs A
J Viral Hepat; 2008 Oct; 15(10):699-709. PubMed ID: 18673428
[TBL] [Abstract][Full Text] [Related]
32. Simeprevir plus peginterferon/ribavirin for HCV genotype 1-infected treatment-naïve patients in China and South Korea.
Wei L; Han T; Yang D; Heo J; Shang J; Cheng J; Chen X; Xie Q; Kim JH; Kalmeijer R; Ouwerkerk-Mahadevan S; Hoeben E; Lenz O; Verbinnen T; Sinha R; Li M; Scott J; Peeters M; Witek J;
J Gastroenterol Hepatol; 2016 May; 31(5):912-20. PubMed ID: 26777137
[TBL] [Abstract][Full Text] [Related]
33. Etanercept as an adjuvant to interferon and ribavirin in treatment-naive patients with chronic hepatitis C virus infection: a phase 2 randomized, double-blind, placebo-controlled study.
Zein NN;
J Hepatol; 2005 Mar; 42(3):315-22. PubMed ID: 15791697
[TBL] [Abstract][Full Text] [Related]
34. Rapid HCV-RNA decline with once daily TMC435: a phase I study in healthy volunteers and hepatitis C patients.
Reesink HW; Fanning GC; Farha KA; Weegink C; Van Vliet A; Van 't Klooster G; Lenz O; Aharchi F; Mariën K; Van Remoortere P; de Kock H; Broeckaert F; Meyvisch P; Van Beirendonck E; Simmen K; Verloes R
Gastroenterology; 2010 Mar; 138(3):913-21. PubMed ID: 19852962
[TBL] [Abstract][Full Text] [Related]
35. Simeprevir with peginterferon and ribavirin leads to high rates of SVR in patients with HCV genotype 1 who relapsed after previous therapy: a phase 3 trial.
Forns X; Lawitz E; Zeuzem S; Gane E; Bronowicki JP; Andreone P; Horban A; Brown A; Peeters M; Lenz O; Ouwerkerk-Mahadevan S; Scott J; De La Rosa G; Kalmeijer R; Sinha R; Beumont-Mauviel M
Gastroenterology; 2014 Jun; 146(7):1669-79.e3. PubMed ID: 24602923
[TBL] [Abstract][Full Text] [Related]
36. Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases.
Rambaldi A; Jacobs BP; Iaquinto G; Gluud C
Cochrane Database Syst Rev; 2005 Apr; (2):CD003620. PubMed ID: 15846671
[TBL] [Abstract][Full Text] [Related]
37. Ribavirin plus interferon versus interferon for chronic hepatitis C.
Brok J; Gluud LL; Gluud C
Cochrane Database Syst Rev; 2005 Jul; (3):CD005445. PubMed ID: 16034976
[TBL] [Abstract][Full Text] [Related]
38. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.
Abdelmalek MF; Firpi RJ; Soldevila-Pico C; Reed AI; Hemming AW; Liu C; Crawford JM; Davis GL; Nelson DR
Liver Transpl; 2004 Feb; 10(2):199-207. PubMed ID: 14762857
[TBL] [Abstract][Full Text] [Related]
39. Bile acids for viral hepatitis.
Chen W; Liu J; Gluud C
Cochrane Database Syst Rev; 2003; (2):CD003181. PubMed ID: 12804455
[TBL] [Abstract][Full Text] [Related]
40. Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study.
Flichman D; Colombatto P; Randone A; Baldi M; Bellati G; Negro F; Oliveri F; Colucci G; Verme G; Bonino F; Brunetto MR
Clin Diagn Virol; 1997 May; 8(1):63-70. PubMed ID: 9248659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
